Nouvelles publications à la Faculté de Pharmacie de Paris (octobre 2018)

Comme tous les mois, la BIU Santé vous propose un rapide panorama des dernières publications des chercheurs de la Faculté de pharmacie de Paris (octobre 2018).

Vous pouvez accéder à ces articles à distance via la BIU Santé (avec vos codes ENT pour les revues électroniques auxquelles nous sommes abonnés).

Si vous ne trouvez pas un article en ligne, adressez-vous à notre service Recherche. Les bibliothécaires peuvent également vous aider à rendre vos articles accessibles à tous via l’Open Access.

Vous trouverez ci-dessous les dernières publications de la faculté, classées par structure de recherche puis par nom de premier auteur. N’hésitez pas à nous contacter en cas d’erreur ou d’omission.

• UMR 216 MERIT Mère et enfant face aux infections tropicales
• UMR-S 1124 Pharmacologie, Toxicologie et Signalisation cellulaire
• UMR-S 1139 Physiopathologie et pharmacotoxicologie placentaire humaine
• UMR-S 1140 Innovations thérapeutiques en hémostase
• UMR-S 1144 Variabilité de réponse aux psychotropes
• UMR-S 1147 Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique
• EA 4064 Epidémiologie environnementale : impact sanitaire des pollutions
• EA 4065 Ecosystème intestinal, probiotiques, antibiotiques
• EA 4466 Prévention et traitement de la perte protéique musculaire en situation de résistance à l’anabolisme
• EA 4475 Pharmacologie de la circulation cérébrale
• EA 7331 Génétique, physiopathologie et approches thérapeutiques des maladies héréditaires du système nerveux
• UMR 8015 Laboratoire de cristallographie et RMN biologiques
• UMR 8258 – Inserm U1022 Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS)
• UMR 8601 Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques
• UMR 8638 Chimie organique médicinale et extractive et toxicologie expérimentale

UMR 216 MERIT Mère et enfant face aux infections tropicales

• Argy, N., Le Gal, S., Coppée, R., Song, Z., Vindrios, W., Massias, L., Kao, W.-C., Hunte, C., Yazdanpanah, Y., Lucet, J.-C., Houzé, S., Clain, J., Nevez, G., 2018. Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients. Clin. Infect. Dis. 67, 913–919. https://doi.org/10.1093/cid/ciy154
• Kamaliddin, C., Joste, V., Argy, N., Houzé, S., 2018. [Fluindione and falciparum malaria treated by atovaquone-proguanil]. Therapie 73, 445–447. https://doi.org/10.1016/j.therap.2018.03.002
• Monedero-Recuero, I., Hernando-Marrupe, L., Sánchez-Montalvá, A., Cox, V., Tommasi, M., Furin, J., Chiang, C.-Y., Quelapio, M., Koura, K.G., Trébucq, A., Padanilam, X., Dravniece, G., Piubello, A., 2018. QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment. Int. J. Tuberc. Lung Dis. https://doi.org/10.5588/ijtld.18.0423
• Jafari-Guemouri, S., Dhiab, J., Massougbodji, A., Deloron, P., Tuikue, N., 2018. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin. Malar. J. 17, 356. https://doi.org/10.1186/s12936-018-2498-8
• Tyagi, R.K., Gleeson, P.J., Arnold, L., Tahar, R., Prieur, E., Decosterd, L., Perignon, J.-L., Olliaro, P., Druilhe, P., 2018. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure. BMC Med. 16, 181. https://doi.org/10.1186/s12916-018-1156-x

UMR-S 1124 Pharmacologie, Toxicologie et Signalisation cellulaire

• Bopp, S.K., Barouki, R., Brack, W., Dalla Costa, S., Dorne, J.-L.C.M., Drakvik, P.E., Faust, M., Karjalainen, T.K., Kephalopoulos, S., van Klaveren, J., Kolossa-Gehring, M., Kortenkamp, A., Lebret, E., Lettieri, T., Nørager, S., Rüegg, J., Tarazona, J.V., Trier, X., van de Water, B., van Gils, J., Bergman, Å., 2018. Current EU research activities on combined exposure to multiple chemicals. Environment International 120, 544–562. https://doi.org/10.1016/j.envint.2018.07.037
• Chierto, E., Simon, A., Castoldi, F., Meffre, D., Cristinziano, G., Sapone, F., Carrete, A., Borderie, D., Etienne, F., Rannou, F., Morrison, B., Massaad, C., Jafarian-Tehrani, M., 2018. Mechanical Stretch of High Magnitude Provokes Axonal Injury, Elongation of Paranodal Junctions, and Signaling Alterations in Oligodendrocytes. Mol Neurobiol. https://doi.org/10.1007/s12035-018-1372-6
• Grandjean, P., Abdennebi-Najar, L., Barouki, R., Cranor, C.F., Etzel, R.A., Gee, D., Heindel, J.J., Hougaard, K.S., Hunt, P., Nawrot, T.S., Prins, G.S., Ritz, B., Soffritti, M., Sunyer, J., Weihe, P., 2018. Time scales of developmental toxicity impacting on research and needs for intervention. Basic Clin. Pharmacol. Toxicol. https://doi.org/10.1111/bcpt.13162
• Joffin, N., Noirez, P., Antignac, J.-P., Kim, M.-J., Marchand, P., Falabregue, M., B, L.B., Forest, C., Emond, C., Barouki, R., Coumoul, X., 2018. Release and toxicity of adipose tissue-stored TCDD: Direct evidence from a xenografted fat model. Environ Int. https://doi.org/10.1016/j.envint.2018.10.027

UMR-S 1139 Physiopathologie et pharmacotoxicologie placentaire humaine

• Berveiller, P., Mir, O., Degrelle, S.A., Tsatsaris, V., Selleret, L., Guibourdenche, J., Evain-Brion, D., Fournier, T., Gil, S., 2018. Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters. Invest New Drugs. https://doi.org/10.1007/s10637-018-0677-7
• Camperi, J., De Cock, B., Pichon, V., Combes, A., Guibourdenche, J., Fournier, T., Vander Heyden, Y., Mangelings, D., Delaunay, N., 2018. First characterizations by capillary electrophoresis of human Chorionic Gonadotropin at the intact level. Talanta 193, 77–86. https://doi.org/10.1016/j.talanta.2018.09.095
• Zitouni, H., Raguema, N., Gannoun, M.B.A., Hebert-Stutter, M., Zouari, I., Maleh, W., Faleh, R., Letaifa, D.B., Almawi, W.Y., Fournier, T., Mahjoub, T., Guibourdenche, J., 2018. Impact of obesity on the association of active renin and plasma aldosterone concentrations, and aldosterone-to-renin ratio with preeclampsia. Pregnancy Hypertension 14, 139–144. https://doi.org/10.1016/j.preghy.2018.09.007

UMR-S 1140 Innovations thérapeutiques en hémostase

• Abbar, B., Vimpere, D., Khater, S., Cellier, C., Diehl, J.-L., 2018. Cerebral infarction following cyanoacrylate endoscopic therapy of duodenal varices in a patient with a patent foramen ovale. Intern Emerg Med 13, 817–819. https://doi.org/10.1007/s11739-018-1892-0
• Blandinières, A., Gille, T., Sadoine, J., Bièche, I., Slimani, L., Dizier, B., Gaussem, P., Chaussain, C., Planes, C., Dorfmüller, P., Israël-Biet, D., Smadja, D.M., 2018. Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice. Stem Cell Rev 14, 812–822. https://doi.org/10.1007/s12015-018-9846-5
• Diehl, J.-L., Mercat, A., Pesenti, A., 2018. Understanding hypoxemia on ECCO2R: back to the alveolar gas equation. Intensive Care Med. https://doi.org/10.1007/s00134-018-5409-0
• Felber, M., Rozet, F., Droupy, S., Misraï, V., Smadja, D.M., Rouprêt, M., 2018. [Venous thromboembolism and urological cancer: Epidemiology and therapeutically management]. Prog. Urol. https://doi.org/10.1016/j.purol.2018.09.002
• Godier, A., Dupont, M., Desilles, J.-P., Guerinel, C.L., Taylor, G., Perrin, M., Martin, A.-C., Gaussem, P., 2018. Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report. TH Open 02, e346–e349. https://doi.org/10.1055/s-0038-1672211
• Martin, A.-C., Godier, A., Narayanan, K., Smadja, D.M., Marijon, E., 2018. Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation. Circulation 138, 627–633. https://doi.org/10.1161/CIRCULATIONAHA.117.033326
• Papageorgiou, C., Jourdi, G., Adjambri, E., Walborn, A., Patel, P., Fareed, J., Elalamy, I., Hoppensteadt, D., Gerotziafas, G.T., 2018. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies. Clin. Appl. Thromb. Hemost. 1076029618806424. https://doi.org/10.1177/1076029618806424

UMR-S 1144 Variabilité de réponse aux psychotropes

• Alladi, C.G., RajKumar, R.P., Adithan, S., Marie-Claire, C., Bellivier, F., Shewade, D.G., 2018. Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia. Fundam Clin Pharmacol. https://doi.org/10.1111/fcp.12424
• Amad, A., Geoffroy, P.A., Micoulaud-Franchi, J.-A., Bensamoun, D., Benzerouk, F., Peyre, H., Yrondi, A., Quilès, C., Fovet, T., 2018. L’examen clinique psychiatrique standardisé pour l’étudiant, c’est possible ! Annales Médico-psychologiques, revue psychiatrique 176, 936–940. https://doi.org/10.1016/j.amp.2018.09.007
• Beaudreuil, S., Schermann, J.M., Verstuyft, C., Barrail‐Tran, A., Smirnova, M., Durrbach, A., Becquemont, L., n.d. Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients. Clinical Transplantation 0, e13405. https://doi.org/10.1111/ctr.13405
• Cleirec, G., Fortias, M., Bloch, V., Clergue-Duval, V., Bellivier, F., Dusouchet, T., Debaulieu, C., Vorspan, F., 2018. Opinion of health professionals and drug users before the forthcoming opening of the first drug consumption room in Paris: a quantitative cross-sectional study. Harm Reduct J 15, 53. https://doi.org/10.1186/s12954-018-0260-8
• Dargél, A.A., Volant, S., Saha, S., Etain, B., Grant, R., Azorin, J.-M., Gard, S., Bellivier, F., Bougerol, T., Kahn, J.-P., Roux, P., Aubin, V., Courtet, P., Leboyer, M., Collaborators, F.-B., Scott, J., Henry, C., 2018. Activation Levels, Cardiovascular Risk, and Functional Impairment in Remitted Bipolar Patients: Clinical Relevance of a Dimensional Approach. PPS 1–3. https://doi.org/10.1159/000493690
• Etain, B., Bellivier, F., 2018. Obesity, mixed and bipolar features in major depression: should we identify the usual suspects or also look for covert mediators? Bipolar Disord. https://doi.org/10.1111/bdi.12712
• Geoffroy, P.A., 2018. Clock Genes and Light Signaling Alterations in Bipolar Disorder: When the Biological Clock Is Off. Biol. Psychiatry 84, 775–777. https://doi.org/10.1016/j.biopsych.2018.09.006
• Geoffroy, P.A., Micoulaud Franchi, J.-A., Maruani, J., Philip, P., Boudebesse, C., Benizri, C., Yeim, S., Benard, V., Brochard, H., Leboyer, M., Bellivier, F., Etain, B., 2018. Clinical characteristics of obstructive sleep apnea in bipolar disorders. J Affect Disord 245, 1–7. https://doi.org/10.1016/j.jad.2018.10.096
• Goud Alladi, C., Etain, B., Bellivier, F., Marie-Claire, C., 2018. DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. International Journal of Molecular Sciences 19, 3026. https://doi.org/10.3390/ijms19103026
• Gourdon, B., Chemin, C., Moreau, A., Arnauld, T., Delbos, J.-M., Péan, J.-M., Declèves, X., 2018. Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport. Eur J Pharm Biopharm 129, 122–133. https://doi.org/10.1016/j.ejpb.2018.05.022
• Karimani, A., Mohammadpour, A.H., Zirak, M.R., Rezaee, R., Megarbane, B., Tsatsakis, A., Karimi, G., 2018. Antidotes for aluminum phosphide poisoning – An update. Toxicol Rep 5, 1053–1059. https://doi.org/10.1016/j.toxrep.2018.10.009
• Luo, H., Gauthier, M., Tan, X., Landry, C., Poupon, J., Dehouck, M.-P., Gosselet, F., Perriere, N., Bellivier, F., Cisternino, S., Decleves, X., 2018. Sodium Transporters Are Involved in Lithium Influx in Brain Endothelial Cells. Mol. Pharm. 15, 2528–2538. https://doi.org/10.1021/acs.molpharmaceut.8b00018
• Mégarbane, B., Lagard, C., Chevillard, L., 2018. Tramadol: Distinguishing the Pathophysiology of Serotonin Syndrome and Seizures. Am. J. Med. 131, e487. https://doi.org/10.1016/j.amjmed.2018.07.005
• Meyrel, M., Veyrier, M., Nieto, I., Bellivier, F., Geoffroy, P.A., 2018. Two Manic Episodes Related to a Levetiracetam-Based Treatment in a 34-Year-Old Female Patient: A Case Report. J Clin Psychopharmacol. https://doi.org/10.1097/JCP.0000000000000978
• Naccache, F., Vorspan, F., 2018. Stratégies de sevrage de benzodiazépines en ambulatoire. Revue de la littérature. La Presse Médicale. https://doi.org/10.1016/j.lpm.2018.10.007
• Reis, R., Labat, L., Allard, M., Boudou-Rouquette, P., Chapron, J., Bellesoeur, A., Thomas-Schoemann, A., Arrondeau, J., Giraud, F., Alexandre, J., Vidal, M., Goldwasser, F., Blanchet, B., 2018. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients. J Pharm Biomed Anal 158, 174–183. https://doi.org/10.1016/j.jpba.2018.05.052
• Richard-Lepouriel, H., Kung, A.-L., Hasler, R., Bellivier, F., Prada, P., Gard, S., Ardu, S., Kahn, J.-P., Dayer, A., Henry, C., Aubry, J.-M., Leboyer, M., Perroud, N., Etain, B., 2019. Impulsivity and its association with childhood trauma experiences across bipolar disorder, attention deficit hyperactivity disorder and borderline personality disorder. J Affect Disord 244, 33–41. https://doi.org/10.1016/j.jad.2018.07.060
• Schlatter, J., Cisternino, S., 2018. Stability of warfarin sodium flavoured preservative-free oral liquid formulations. Eur J Hosp Pharm 25, e98–e101. https://doi.org/10.1136/ejhpharm-2017-001281
• Vodovar, D., Megarbane, B., 2018. Ephenidine, diphenidine and methoxphenidine complications reported to the French Addictovigilance Network: another brick in the wall! Fundam Clin Pharmacol 32, 652–653. https://doi.org/10.1111/fcp.12407
• Vodovar, D., Mégarbane, B., 2017. Prognosis and outcome of severe lithium poisoning. J. Psychopharmacol. (Oxford) 31, 1274–1277. https://doi.org/10.1177/0269881117699168
• Vorspan, F., Barré, T., Pariente, A., Montastruc, F., Tournier, M., 2018. Faut-il limiter la durée des traitements par benzodiazépines ? La Presse Médicale. https://doi.org/10.1016/j.lpm.2018.10.006

UMR-S 1147 Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique

• Barritault, M., Lupo, A.M., Vendroux, A.J., Zarmaev, M., Bony, A., alifano, M., Regnard, J.-F., Laurent-Puig, P., Damotte, D., Blons, H., 2018. Adénocarcinomes multiples pulmonaires : apport de la biologie moléculaire et de l’histologie pour distinguer les tumeurs multi-primitives des métastases. Morphologie, 100e congrès de l’Association des morphologistes, 23e journées du collège des histologistes, embryologistes et cytogénéticiens, Caen, 22-24 mars 2018,  102, 145. https://doi.org/10.1016/j.morpho.2018.07.109
• Berrandou, T., Cordina-Duverger, E., Mulot, C., Truong, T., Guénel, P., 2018. Persistent organochlorine pollutants: genetic variations associated with p,p’-DDE and PCB153 blood levels among women in France. Genetic Epidemiology 42, 689. https://doi.org/10.1002/gepi.22163
• Gallois, C., Taieb, J., Le Corre, D., Le Malicot, K., Tabernero, J., Mulot, C., Seitz, J.-F., Aparicio, T., Folprecht, G., Lepage, C., Mini, E., Van Laethem, J.-L., Emile, J.-F., Laurent-Puig, P., 2018. Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy. Clin. Cancer Res. 24, 4745–4753. https://doi.org/10.1158/1078-0432.CCR-18-0866
• Hamard, C., Mignard, X., Pecuchet, N., Mathiot, N., Blons, H., Laurent-Puig, P., Leroy, K., Lupo, A., Chapron, J., Giraud, F., Arrondeau, J., Goldwasser, F., Alifano, M., Damotte, D., Wislez, M., 2018. IHC, FISH, CISH, NGS dans les cancers bronchiques non à petites cellules : quelles évolutions dans l’ère des biomarqueurs ? Revue de Pneumologie Clinique, Carte blanche à l’hôpital Cochin 74, 327–338. https://doi.org/10.1016/j.pneumo.2018.09.013
• Moati, E., Taly, V., Didelot, A., Perkins, G., Blons, H., Taieb, J., Laurent-Puig, P., Zaanan, A., 2018. Role of circulating tumor DNA in the management of patients with colorectal cancer. Clin. Res. Hepatol. Gastroenterol. 42, 396–402. https://doi.org/10.1016/j.clinre.2018.03.002
• Pilati, C., Laurent-Puig, P., 2018. Colorectal cancer: From molecular to clinical consensus? Hépato-Gastro & Oncologie Digestive 25, 645–649. https://doi.org/10.1684/hpg.2018.1642
• Tlemsani, C., Leroy, K., Gimenez-Roqueplo, A.-P., Mansuet-Lupo, A., Pasmant, E., Larousserie, F., Boudou-Rouquette, P., Vidaud, M., Cadranel, J., Blons, H., Goldwasser, F., Laurent-Puig, P., 2018. Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options. J. Med. Genet. https://doi.org/10.1136/jmedgenet-2018-105594